August 29, 2023

Chimeric Therapeutics (ASX:CHM) announced the successful treatment of the third participant, required to complete the fourth and final planned dose escalation cohort, in the CHM 1101 Phase 1A clinical trial, has been completed at City of Hope. In response, Jennifer Chow, CEO and Managing Director commented, “We look forward to providing an update on the

Consumer confidence in Australia, as measured by the ANZ-Roy Morgan survey, saw a 2.3-point increase in the past week. Notably, confidence went up in New South Wales, Victoria, and Queensland, while it declined in South Australia and Western Australia. The survey also indicated a 0.3% decrease in weekly inflation expectations, settling at 5.2%. The four-week

Chinese electric vehicle (EV) giant, BYD, announced a remarkable 207% increase in earnings during the first half of this year, propelled by record-breaking production and sales figures. The company’s dominance in the new energy vehicle (NEV) market, including batteries and plug-in electrified vehicles, further solidified its status as China’s leading auto brand. This news holds

Embattled casino group, Star Entertainment (ASX:SGR), has posted a staggering loss of $2.4 billion for the fiscal year ending on June 30, primarily due to substantial write-downs in the value of its casinos exceeding $2 billion. The company informed the ASX that it had devalued The Star Sydney, The Star Gold Coast, and Treasury Brisbane